122 related articles for article (PubMed ID: 11826522)
1. [Sensitivity of clinical isolates of Candida albicans to 5-fluorocytosine].
Fernández Andreu CM; Lemus Molina D; Martínez Machín G
Rev Cubana Med Trop; 2000; 52(3):191-6. PubMed ID: 11826522
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility to 5-fluorocytosine, miconazole and amphotericin B of Candida albicans strains isolated from the throat of non-AIDS patients.
Paniagua GL; Monroy E; Negrete E; Vaca S
Rev Latinoam Microbiol; 2002; 44(2):65-8. PubMed ID: 17063773
[TBL] [Abstract][Full Text] [Related]
3. [Investigation of quantitative and species composition and antifungal drug susceptibility of yeasts isolated from patients with generalized periodontitis complicated by candidosis].
Kutsyk RV; Pavliuk TD
Mikrobiol Z; 2003; 65(5):26-9. PubMed ID: 14723159
[TBL] [Abstract][Full Text] [Related]
4. [The relationship between Candida albicans 25S intron genotypes and antifungal susceptibilities].
Balaban N; Karahan ZC; Mumcuoğlu I; Cayirli A; Kuştimur S
Mikrobiyol Bul; 2007 Apr; 41(2):245-51. PubMed ID: 17682711
[TBL] [Abstract][Full Text] [Related]
5. 5-Fluorocytosine and Candida yeasts.
Fabbri A; Tacchella A; Belli ML; Toriello E
Chemioterapia; 1987 Feb; 6(1):8-11. PubMed ID: 3549011
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo antifungal activity of the combination methylpartricin-5-fluorocytosine.
Strippoli V; Torosantucci A; Simonetti N
Chemioterapia; 1984 Apr; 3(2):119-25. PubMed ID: 6398120
[TBL] [Abstract][Full Text] [Related]
7. [Sensitivity in vitro of opportunist yeasts (Candida albicans and Torulopsis glabrata) to flucytosine and concordance curves (author's transl)].
Slim A; Bergogne-Berezin E; Courtoux D
Ann Biol Clin (Paris); 1978; 36(2):69-74. PubMed ID: 358866
[TBL] [Abstract][Full Text] [Related]
8. [Candida albicans resistance and genotyping by randomly amplified polymorphic DNA method].
Qian J; Zha GZ; Yu P
Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):327-30. PubMed ID: 12205990
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of clinical isolates of Candida lusitaniae to five systemic antifungal agents.
Favel A; Michel-Nguyen A; Datry A; Challier S; Leclerc F; Chastin C; Fallague K; Regli P
J Antimicrob Chemother; 2004 Mar; 53(3):526-9. PubMed ID: 14963064
[TBL] [Abstract][Full Text] [Related]
10. [The value of the agar dilution method as a screening test for determining the sensitivity of Candida albicans to fluconazole].
Yücesoy M; Marol S
Mikrobiyol Bul; 2002; 36(3-4):317-22. PubMed ID: 12838666
[TBL] [Abstract][Full Text] [Related]
11. [The comparison of susceptibility of Candida albicans and Candida glabrata to miconazole].
Kurnatowski P; Makieło L; Horwatt-Bozyczko E
Wiad Parazytol; 2001; 47(4):867-73. PubMed ID: 16886440
[TBL] [Abstract][Full Text] [Related]
12. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S
J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
[TBL] [Abstract][Full Text] [Related]
13. In vitro antifungal activity of 2,5 disubstituted amino-oksometyloso-arylo-thiadiazole derivatives.
Lukaszuk C; Krajewska-Kułak E; Niewiadomy A; Stachowicz J; Głaszcz U; Oksiejczuk E
Adv Med Sci; 2007; 52 Suppl 1():26-9. PubMed ID: 18229628
[TBL] [Abstract][Full Text] [Related]
14. Antifungal resistance in Candida spp. isolated in Italy between 2002 and 2005 from children and adults.
Gualco L; Debbia EA; Bandettini R; Pescetto L; Cavallero A; Ossi MC; Schito AM; Marchese A
Int J Antimicrob Agents; 2007 Feb; 29(2):179-84. PubMed ID: 17175140
[TBL] [Abstract][Full Text] [Related]
15. Antifungal susceptibility and genotypes of Candida albicans strains from patients with vulvovaginal candidiasis.
Liu XP; Fan SR; Bai FY; Li J; Liao QP
Mycoses; 2009 Jan; 52(1):24-8. PubMed ID: 18498300
[TBL] [Abstract][Full Text] [Related]
16. Derivation of an in vivo drug exposure breakpoint for flucytosine against Candida albicans and Impact of the MIC, growth rate, and resistance genotype on the antifungal effect.
Hope WW; Warn PA; Sharp A; Howard S; Kasai M; Louie A; Walsh TJ; Drusano GL; Denning DW
Antimicrob Agents Chemother; 2006 Nov; 50(11):3680-8. PubMed ID: 16954320
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of candida isolates from denture-related stomatitis to antifungal agents in vitro.
Dorocka-Bobkowska B; Konopka K
Int J Prosthodont; 2007; 20(5):504-6. PubMed ID: 17944341
[TBL] [Abstract][Full Text] [Related]
18. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
Oz Y; Akşit F; Kiraz N; Kiremitçi A
Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
[TBL] [Abstract][Full Text] [Related]
19. [Molecular epidemiologic surveillance and antifungal agent sensitivity of Candida albicans isolated from anesthesia intensive care units].
Gülay Z; Ergon C; Ozkütük A; Yücesoy M; Biçmen M
Mikrobiyol Bul; 2002; 36(3-4):309-16. PubMed ID: 12838665
[TBL] [Abstract][Full Text] [Related]
20. Broth dilution and disc diffusion methods in the susceptibility testing of pathogenic Candida albicans against four antimycotics.
Kostiala AA; Kostiala I
Mycopathologia; 1984 Aug; 87(1-2):121-7. PubMed ID: 6092958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
